English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2523020      線上人數 : 179
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6407


    題名: 水解型單寧Geraniin在家兔體內之藥物動力學研究
    Pharmacokinetic Studies of Ellagitannin Geraniin in Rabbits
    作者: 謝明樺
    Ming_Hua Hsieh
    貢獻者: 藥學研究所
    關鍵詞: Geraniin
    藥物動力學
    家兔
    靜脈注射
    Geraniin
    Pharmacokinetics
    Rabbits
    I.V. administration
    日期: 2000
    上傳時間: 2009-09-11 16:54:19 (UTC+8)
    摘要: 中文摘要
    自牻牛兒苗分離出的geraniin是一廣泛存在的ellagitannin,並具有dehydrohexahydroxydiphenoyl (DHHDP)結構。先前的研究中已發現geraniin具有止瀉、腸胃道保護功能、黑色素腫瘤細胞毒殺作用、並能強化巨噬細胞之吞噬作用及酸磷酸酵素、對微粒體具有抗脂質過氧化作用、亦能降低老鼠之GOT、 GPT、LPO、TG及free fatty acid。此外,在老鼠試驗中更發現有降血壓的效果。僅管在藥理作用上已被廣泛研究,但在藥物動力學上的研究卻仍未被研究。為了對geraniin在生物體內的動態,能有更能有完整的瞭解,本實驗將geraniin投與至家兔體內,以觀察geraniin在家兔體內的藥物動力學表現。
    一精確、簡單並具有專一性的HPLC分析方法已被發展出來用以偵測生物檢品中geraniin的濃度。利用phenyl逆相層析管,在UV波長280nm進行偵測。在血漿濃度0.1mg到 100mg/ml的濃度範圍內,呈現良好之線性關係(Y=0.0008+0.0488X, r2=0.9922),同日內其與異日內分析的C.V.值均在可接受範圍內,顯示此為良好之分析方法。
    經由三個不同之劑量(1、2、 5mg/kg)靜脈投予六隻兔子,並分析其血漿濃度,顯示geraniin在此劑量下符合二室性模式之藥物動力學性質。排除半衰期分別為70.63*14.65、81.76*15.04、81.34 * 4.46分鐘。清除率為2.08*0.81、 2.18*0.62、2.89*0.64 ml/min./kg,各項藥物動力學參數並無統計上差異,顯示geraniin在此劑量範圍內呈現良好線性之藥物動力學性質。曲線下面積(AUC)分別為551.77*232.72、985.23*296.15、1819.59*504.75 mg*min/ml,與劑量呈現良好之比例關係(Y=297.5460+307.9935X,r2=0.7081,P<0.001.)。而腎清除率分別為0.18*0.06、0.12*0.07及0.15*0.05 ml/min/kg,佔總清除率的9.20*3.52 %、5.14*2.04 %及5.42*1.64 %,顯示geraniin之非腎臟排除佔極重要部份。
    經口投與5、50、100、250mg/kg geraniin至家兔體內並分析其結果,發現血液中geraniin濃度於6小時內均小於0.1mg/ml。由安定性試驗中得知geraniin在胃液中及鹼性環境下相當不安定。因此口服投與geraniin之吸收不良可能是由於腸胃道的不安定所致。
    由上述結果可知,geraniin在1~5mg/kg以靜脈投與至家兔體內,呈現非劑量依賴之藥藥物動力學性質特性,並以非腎臟排除為主要排除途徑。經口投與5~250mg/kg geraniin之吸收不良,則可能主要是由於腸胃道的不安定所致。
    Abstract
    Geraniin, one of the major components isolated from Geranium thunbergii Sieb. et Zucc., is a widely distributed ellagitannin with a dehydrohexahydroxydiphenoyl (DHHDP) moiety. In previous studies, geraniin has been demonstrated to antidiarrhea and cytoprotective effect; potent cytotoxicity in melanoma tumor cells with ED50=0.35μg/ml; enhancement of phagocytosis and acid phosphatase activity in macrophage; anti-lipid peroxydation in mitochondria; lowing the GOT, GPT, LPO, TG and free fatty acid in rat; anti-inflammatory, antinociceptive effect, cytoprotective effect and anti-hypertensive action in rat. Although several pharmacological effects has been reported, but the pharmacokinetics of geraniin has not been studied.
    An accuracy, simple and specific analytical method based on HPLC was developed to detect the geraniin in the biological sample firstly. A phenyl reversed phase column with UV detection at 280nm was used in chromatographic separation. Under these chromatographic conditions, the calibration curve of plasma shows a good linearity within the concentration range of 0.1mg to 100mg/ml (Y=0.0008+ 0.0488X, r2=0.9922). The validations of this analytical method are within the acceptable criteria.
    The pharmacokinetics of geraniin was studied by intravenous administration of three different doses (1, 2, 5mg/kg) to six rabbits, respectively. The plasma concentration-time profiles of geraniin could be described by a bi-exponential equation with each dose. The elimination half-lives are 70.63*14.65, 81.76*15.04, 81.34*4.46 minutes, and the systemic clearance are 2.08*0.81, 2.18*0.62, 2.89*0.64 ml/min./kg. These data show a linear pharmacokinetic property of geraniin in rabbits between 1~5mg/kg with intravenous administration. The area under the curves (AUC) calculated from time zero to infinite are 551.77*232.72, 985.23*296.15, 1819.59*504.75 mg*min/ml. A good linear relationship between dose and AUC is obtained, Y=297.5460+307.9935X, r2=0.7081, P<0.001.The renal clearance are 0.18*0.06, 0.12*0.07 and 0.15*0.05 ml/min/kg, they are 9.20*3.52%, 5.14*2.04 % and 5.42*1.64 % of total clearance, respectively. It indicated that the nonrenal clearance of geraniin play an important role in elimination.
    After oral administration of geraniin 5, 50, 100, 250mg/kg to rabbits, the concentration of geraniin in plasma is lower than 0.1mg/ml. According to the stability test, geraniin is quite unstable in gastric acid and basic conditions. It is suggested that unstable in gut results in poor absorption after oral administration of geraniin.
    From these data in above, geraniin shows a dose-independent pharmacokinetic property with mainly nonrenal clearance elimination after I.V. administration of 1~5mg/kg geraniin to rabbits. The unstability of geraniin in gut may be the major reason of poor absorption after P.O. administration of 5~250mg/kg geraniin to rabbits.
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc33KbMicrosoft Word125檢視/開啟
    摘要.pdf108KbAdobe PDF170檢視/開啟
    摘要.ppt120KbMicrosoft Powerpoint88檢視/開啟
    摘要.ps617KbPostscript96檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋